Tumor hla a2 antigen. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy18

Cell Line, Tumor T-Lymphocytes Cell Line Cells, Cultured B-Lymphocytes CD8-Positive T-Lymphocytes Spleen Clone Cells Dendritic Cells CD4-Positive T-Lymphocytes T-Lymphocytes, Cytotoxic Lymphocytes Immune Sera Lymph Nodes Antigen-Presenting Cells Macrophages Killer Cells, Natural Lymphocytes, Tumor-Infiltrating

Organisms9

Mice, Inbred BALB C Mice, Inbred C57BL Mice, Transgenic Mice, SCID Mice, Inbred Strains Mice, Nude Simian virus 40 Rabbits Mice, Knockout

Diseases49

Neoplasms, Experimental Wilms Tumor Carcinoid Tumor Neuroendocrine Tumors Brain Neoplasms Mammary Neoplasms, Experimental Adenocarcinoma Neoplasm Metastasis Neovascularization, Pathologic Neoplasms Colonic Neoplasms Gastrointestinal Stromal Tumors Cell Transformation, Neoplastic Liver Neoplasms Skin Neoplasms Fibrosarcoma Kidney Neoplasms Ovarian Neoplasms Sarcoma, Experimental Melanoma, Experimental Carcinoma, Ehrlich Tumor Glioma Carcinoma, Squamous Cell Disease Models, Animal Pancreatic Neoplasms Disease Progression Lymphoma Rhabdoid Tumor Granulosa Cell Tumor Breast Neoplasms Neoplasm Recurrence, Local Mammary Neoplasms, Animal Carcinoma, Hepatocellular Bone Neoplasms Glioblastoma Tumor Virus Infections Phyllodes Tumor Lymphatic Metastasis Astrocytoma Adenoma Neuroectodermal Tumors, Primitive Gastrointestinal Neoplasms Glomus Tumor Giant Cell Tumor of Bone Giant Cell Tumors Liver Neoplasms, Experimental Meningioma Dog Diseases Urinary Bladder Neoplasms

Chemicals and Drugs106

HLA Antigens Antigens Antigens, Neoplasm Antigens, Bacterial Antigens, Surface Antigens, Viral Tumor Markers, Biological Tumor Necrosis Factor-alpha Antigens, Polyomavirus Transforming HLA-DR Antigens Antigens, Protozoan Antibodies, Monoclonal Antigens, Viral, Tumor Carcinoembryonic Antigen Antigens, Fungal HLA-A Antigens Antigens, CD H-2 Antigens HLA-B Antigens Antigens, Helminth Histocompatibility Antigens Class I Histocompatibility Antigens Class II Tumor Suppressor Protein p53 Epitopes HLA-A2 Antigen Histocompatibility Antigens Receptors, Antigen, T-Cell Proliferating Cell Nuclear Antigen HLA-DQ Antigens Tumor Suppressor Proteins Prostate-Specific Antigen HLA-D Antigens Antigens, Tumor-Associated, Carbohydrate Neoplasm Proteins Receptors, Antigen, B-Cell Immunoglobulin G Antigens, CD8 O Antigens RNA, Messenger Antigens, CD15 Antigens, CD3 Hepatitis B Surface Antigens Interferon-gamma Blood Group Antigens HLA-C Antigens Cancer Vaccines Antigens, CD45 Ki-67 Antigen Antigens, CD4 Recombinant Proteins Antibodies DNA, Neoplasm Receptors, Antigen Antigens, Differentiation MART-1 Antigen Antigens, CD1 HLA-DRB1 Chains Hepatitis B Antigens HLA-DQ beta-Chains Antigens, CD80 HLA-DR3 Antigen HLA-B7 Antigen Antibodies, Bacterial Peptides Immune Sera HLA-DR4 Antigen Cytokines HLA-B27 Antigen HLA-A1 Antigen Autoantigens Epitopes, T-Lymphocyte HIV Antigens Antigens, CD40 Membrane Proteins Antigens, CD19 Antigens, Heterophile Recombinant Fusion Proteins Epstein-Barr Virus Nuclear Antigens Glycoproteins Antigen-Antibody Complex HLA-B44 Antigen Receptors, Tumor Necrosis Factor, Type I Antigens, CD95 Immunoglobulin M Peptide Fragments Autoantibodies gp100 Melanoma Antigen DNA Primers Receptors, Antigen, T-Cell, alpha-beta HLA-B8 Antigen Antigens, CD86 Hepatitis B Core Antigens Isoantibodies Antigens, Thy-1 Ovalbumin CA-19-9 Antigen CTLA-4 Antigen DNA-Binding Proteins CA-125 Antigen H-Y Antigen Forssman Antigen DNA Probes, HLA Interleukin-2 RNA, Neoplasm HLA-B35 Antigen HLA-A24 Antigen

Analytical, Diagnostic and Therapeutic Techniques and Equipment40

Tumor Burden Neoplasms, Experimental Enzyme-Linked Immunosorbent Assay Mammary Neoplasms, Experimental Lymphocyte Activation Immunoenzyme Techniques Flow Cytometry Transplantation, Heterologous Histocompatibility Testing Immunohistochemistry Fluorescent Antibody Technique Xenograft Model Antitumor Assays Blotting, Western Reverse Transcriptase Polymerase Chain Reaction Transfection Polymerase Chain Reaction Sarcoma, Experimental Immunization Neoplasm Staging Melanoma, Experimental Sensitivity and Specificity Disease Models, Animal Treatment Outcome Neoplasm Transplantation Retrospective Studies Survival Analysis Gene Expression Profiling Tumor Stem Cell Assay Cytotoxicity Tests, Immunologic Immunoblotting Combined Modality Therapy Tomography, X-Ray Computed Survival Rate Immunodiffusion Immunotherapy Immunotherapy, Adoptive Liver Neoplasms, Experimental Complement Fixation Tests Electrophoresis, Polyacrylamide Gel Cloning, Molecular

Phenomena and Processes38

Genes, Tumor Suppressor Tumor Microenvironment Lymphocyte Activation Amino Acid Sequence Cell Division Cell Proliferation Base Sequence Time Factors Cross Reactions Antibody Specificity Cytotoxicity, Immunologic Mutation Signal Transduction Transfection Alleles Antigen-Antibody Reactions Antibody Formation Sensitivity and Specificity Phenotype Gene Expression Immunity, Cellular Cell Survival Genes, MHC Class II Major Histocompatibility Complex Gene Expression Regulation, Neoplastic Genes, MHC Class I Molecular Weight Tissue Distribution Cell Movement Cell Differentiation Genetic Vectors Down-Regulation Protein Binding Dose-Response Relationship, Drug Immune Tolerance Promoter Regions, Genetic Up-Regulation Apoptosis

Disciplines and Occupations1

Immunohistochemistry

Information Science4

Molecular Sequence Data Amino Acid Sequence Base Sequence Survival Rate

Health Care6

Immunization Sensitivity and Specificity Treatment Outcome Retrospective Studies Survival Analysis Survival Rate

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Information Science Health Care

HLA Antigens Antigens Antigens, Neoplasm Antigens, Bacterial Antigens, Surface Antigens, Viral Tumor Markers, Biological Tumor Necrosis Factor-alpha Tumor Burden Cell Line, Tumor Antigens, Polyomavirus Transforming HLA-DR Antigens Antigens, Protozoan Antibodies, Monoclonal Neoplasms, Experimental Antigens, Viral, Tumor Carcinoembryonic Antigen Wilms Tumor Mice, Inbred BALB C Antigens, Fungal HLA-A Antigens Antigens, CD H-2 Antigens HLA-B Antigens Antigens, Helminth Genes, Tumor Suppressor Histocompatibility Antigens Class I Histocompatibility Antigens Class II Tumor Suppressor Protein p53 Carcinoid Tumor Epitopes Molecular Sequence Data T-Lymphocytes HLA-A2 Antigen Cell Line Histocompatibility Antigens Receptors, Antigen, T-Cell Proliferating Cell Nuclear Antigen HLA-DQ Antigens Mice, Inbred C57BL Neuroendocrine Tumors Tumor Suppressor Proteins Brain Neoplasms Enzyme-Linked Immunosorbent Assay Tumor Microenvironment Prostate-Specific Antigen HLA-D Antigens Mammary Neoplasms, Experimental Adenocarcinoma Antigens, Tumor-Associated, Carbohydrate Lymphocyte Activation Neoplasm Proteins Immunoenzyme Techniques Flow Cytometry Neoplasm Metastasis Receptors, Antigen, B-Cell Amino Acid Sequence Neovascularization, Pathologic Cell Division Immunoglobulin G Transplantation, Heterologous Cell Proliferation Antigens, CD8 Base Sequence O Antigens RNA, Messenger Cells, Cultured Histocompatibility Testing Time Factors Antigens, CD15 Cross Reactions Neoplasms Immunohistochemistry Antigens, CD3 Colonic Neoplasms Fluorescent Antibody Technique Antibody Specificity Cytotoxicity, Immunologic Gastrointestinal Stromal Tumors Xenograft Model Antitumor Assays Cell Transformation, Neoplastic Mice, Transgenic Liver Neoplasms Mutation Hepatitis B Surface Antigens Interferon-gamma Blood Group Antigens Signal Transduction Blotting, Western Reverse Transcriptase Polymerase Chain Reaction Transfection Alleles HLA-C Antigens B-Lymphocytes Skin Neoplasms Fibrosarcoma Mice, SCID Polymerase Chain Reaction Kidney Neoplasms Ovarian Neoplasms

No FAQ available that match "tumor hla a2 antigen"